WO2008066878A3 - Methods and products for diagnosing cancer - Google Patents
Methods and products for diagnosing cancer Download PDFInfo
- Publication number
- WO2008066878A3 WO2008066878A3 PCT/US2007/024553 US2007024553W WO2008066878A3 WO 2008066878 A3 WO2008066878 A3 WO 2008066878A3 US 2007024553 W US2007024553 W US 2007024553W WO 2008066878 A3 WO2008066878 A3 WO 2008066878A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- cancer
- products
- diagnosing cancer
- detection
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 230000011987 methylation Effects 0.000 abstract 3
- 238000007069 methylation reaction Methods 0.000 abstract 3
- -1 PCSKl Proteins 0.000 abstract 2
- 208000006994 Precancerous Conditions Diseases 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 102100025331 Cadherin-8 Human genes 0.000 abstract 1
- 102100029846 Glutaminyl-peptide cyclotransferase Human genes 0.000 abstract 1
- 101000935095 Homo sapiens Cadherin-8 Proteins 0.000 abstract 1
- 101000585315 Homo sapiens Glutaminyl-peptide cyclotransferase Proteins 0.000 abstract 1
- 101000619665 Homo sapiens Leucine-rich repeat-containing protein 2 Proteins 0.000 abstract 1
- 101000575378 Homo sapiens Microfibrillar-associated protein 2 Proteins 0.000 abstract 1
- 102100022236 Leucine-rich repeat-containing protein 2 Human genes 0.000 abstract 1
- 102100025599 Microfibrillar-associated protein 2 Human genes 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention relates to methods and kits for the detection and diagnosis of cancer or precancerous conditions. Methylation of specific genes has been identified as indicative of cancer and methods of the invention, in part, relate to the detection of methylation levels in cells as a determination of cancer or a precancerous condition in the cell. In particular, the methylation levels of QPCT, LXN, PCSKl, MFAP2, WFDCl, CDH8 and LRRC2 in melanoma is measured.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/312,807 US20100143899A1 (en) | 2005-05-17 | 2007-11-29 | Methods and products for diagnosing cancer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86175506P | 2006-11-29 | 2006-11-29 | |
US60/861,755 | 2006-11-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2008066878A2 WO2008066878A2 (en) | 2008-06-05 |
WO2008066878A3 true WO2008066878A3 (en) | 2008-12-11 |
WO2008066878A9 WO2008066878A9 (en) | 2009-05-28 |
Family
ID=39468508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/024553 WO2008066878A2 (en) | 2005-05-17 | 2007-11-29 | Methods and products for diagnosing cancer |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008066878A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8445442B2 (en) | 2007-04-26 | 2013-05-21 | University Of Vermont And State Agricultural College | CCL18 and CCL3 methods and compositions for detecting and treating cancer |
US20110076283A1 (en) * | 2008-01-24 | 2011-03-31 | Universite De Lausanne | Method for predicting and diagnosing brain tumor |
CN101962684B (en) * | 2010-11-04 | 2012-03-28 | 徐州师范大学 | Single nucleotide polymorphism for cattle PCSK1 gene and detection method thereof |
WO2012081017A1 (en) | 2010-12-15 | 2012-06-21 | Yeda Research And Development Co. Ltd. | Compositions and methods for treating cancer and neurodegenerative diseases |
EP3037545A1 (en) * | 2014-12-23 | 2016-06-29 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | A DNA-methylation test for prostate cancer |
WO2020019268A1 (en) * | 2018-07-26 | 2020-01-30 | 北京艾克伦医疗科技有限公司 | Method for identifying state of breast cancer and kit |
CN114410792B (en) * | 2022-02-10 | 2023-07-25 | 博尔诚(北京)科技有限公司 | Marker for kidney cancer screening, probe composition and application thereof |
CN118441051B (en) * | 2024-05-28 | 2025-05-02 | 南通大学 | MeQTL-SNPs biomarker related to lung adenocarcinoma and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005095644A2 (en) * | 2004-04-04 | 2005-10-13 | Oligene Gmbh | Method for recognizing signatures in complex gene expression profiles |
WO2007149269A2 (en) * | 2006-06-12 | 2007-12-27 | Oncomethylome Sciences S.A. | Methylation markers for early detection and prognosis of colon cancers |
-
2007
- 2007-11-29 WO PCT/US2007/024553 patent/WO2008066878A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005095644A2 (en) * | 2004-04-04 | 2005-10-13 | Oligene Gmbh | Method for recognizing signatures in complex gene expression profiles |
WO2007149269A2 (en) * | 2006-06-12 | 2007-12-27 | Oncomethylome Sciences S.A. | Methylation markers for early detection and prognosis of colon cancers |
Non-Patent Citations (5)
Title |
---|
FURUTA JUNICHI ET AL: "Silencing of the thrombomodulin gene in human malignant melanoma", MELANOMA RESEARCH, vol. 15, no. 1, February 2005 (2005-02-01), pages 15 - 20, XP009103389, ISSN: 0960-8931 * |
GILLIS JOHN STUART: "Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy", JOURNAL OF TRANSLATIONAL MEDICINE, BIOMED CENTRAL, LONDON, GB, vol. 4, no. 1, 4 July 2006 (2006-07-04), pages 27, XP021018978, ISSN: 1479-5876 * |
KORABIOWSKA MONIKA ET AL: "Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours", MODERN PATHOLOGY, vol. 17, no. 12, December 2004 (2004-12-01), pages 1539 - 1544, XP002489097, ISSN: 0893-3952 * |
MIRMOHAMMADSADEGH ALIREZA ET AL: "Epigenetic silencing of the PTEN gene in melanoma.", CANCER RESEARCH 1 JUL 2006, vol. 66, no. 13, 1 July 2006 (2006-07-01), pages 6546 - 6552, XP002489096, ISSN: 0008-5472 * |
MUTHUSAMY VISWANATHAN ET AL: "Epigenetic silencing of novel tumor suppressors in malignant melanoma", CANCER RESEARCH, vol. 66, no. 23, December 2006 (2006-12-01), pages 11187 - 11193, XP002489098, ISSN: 0008-5472 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008066878A9 (en) | 2009-05-28 |
WO2008066878A2 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008066878A3 (en) | Methods and products for diagnosing cancer | |
WO2009115615A3 (en) | Detection and prognosis of cervical cancer | |
WO2009037572A3 (en) | Biomarker combinations for colorectal cancer | |
WO2009011971A3 (en) | Primers and probes for the detection of streptococcus pneumoniae | |
WO2013093635A3 (en) | Plasma micrornas for the detection of early colorectal cancer | |
WO2009111470A3 (en) | Protease assay | |
WO2012096545A3 (en) | Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof | |
WO2011055916A3 (en) | Method for detecting the methylation of colon-cancer-specific methylation marker genes for colon cancer diagnosis | |
WO2012074904A3 (en) | Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents | |
MX2011011571A (en) | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy. | |
WO2007135369A3 (en) | Spsis detection microarray | |
WO2010089538A9 (en) | Methods of detecting colorectal cancer | |
WO2009102446A3 (en) | Fish assay for eml4 and alk fusion in lung cancer | |
NZ624609A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
MX2013000502A (en) | Methods and kits for the diagnosis of prostate cancer. | |
WO2009129505A3 (en) | Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid | |
WO2007028031A3 (en) | Methods and probe combinations for detecting melanoma | |
NZ605698A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
WO2006133923A3 (en) | Diagnosis, prognosis and prediction of recurrence of breast cancer | |
WO2011085163A3 (en) | Protein markers for lung cancer detection and methods of using thereof | |
WO2009083950A3 (en) | Biomarkers for the prediction of renal injury | |
WO2010034794A3 (en) | Methods and kits for the diagnosis and the staging of colorectal cancer | |
WO2012033537A8 (en) | Benchmarks for normal cell identification | |
WO2008055153A3 (en) | Gene reporter assay, kit and cells with improved sensitivity and/or specificity for determining the level of an extracellular signal | |
WO2006047536A3 (en) | Methods and kits for detecting mutations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07862317 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12312807 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07862317 Country of ref document: EP Kind code of ref document: A2 |